Plain-English translation of NCT04634240 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Many patients who need a new aortic valve also have blocked coronary arteries—the vessels that deliver blood to the heart muscle itself. This study is testing whether patients should routinely have these arteries opened with a catheter procedure (called angioplasty, which places a stent to keep the artery open), or whether taking heart medications alone is safer and just as effective. The researchers want to know which approach prevents more heart attacks, heart-related deaths, and other serious heart problems over five years.
Doctors disagree about the best way to handle blocked arteries in patients getting a new valve. Some hospitals open the blocked arteries routinely; others treat them only with medication. This trial exists to give doctors clear, evidence-based answers so they can make the safest choice for every patient.
You likely qualify if…
You likely don't qualify if…
After your new valve is successfully placed, you will be randomly assigned to one of two groups: one group will receive a catheter procedure to open any blocked arteries (which may happen within the first month after your valve surgery), while the other group will manage their blocked arteries with medication alone. Both groups will receive the same heart medications. You will have follow-up visits and testing over five years to track your heart health and watch for any heart-related events or complications.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
United States